Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.

BACKGROUND: Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who trial clozapine have an inadequate response and experience persistent symptoms,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Technol Assess
Main Authors: Morrison, Anthony P, Pyle, Melissa, Gumley, Andrew, Schwannauer, Matthias, Turkington, Douglas, MacLennan, Graeme, Norrie, John, Hudson, Jemma, Bowe, Samantha, French, Paul, Hutton, Paul, Byrne, Rory, Syrett, Suzy, Dudley, Robert, McLeod, Hamish J, Griffiths, Helen, Barnes, Thomas Re, Davies, Linda, Shields, Gemma, Buck, Deborah, Tully, Sarah, Kingdon, David
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409493/
https://ncbi.nlm.nih.gov/pubmed/30806619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta23070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados